Author

Tong-Hua Yang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Oct 2026

Felzartamab plus lenalidomide-dexamethasone versus lenalidomide-dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial.

BACKGROUND Complement-dependent cytotoxicity (CDC) of CD38 monoclonal antibodies has been associated with infusion-related reactions and might contribute to reduced clinical efficacy of CDC-reliant CD38 antibodies, particularly in patients with relapsed or refractory multiple myeloma with 1q21+. We aimed to evaluate fe...

Hai-Yan He, J. Shang, Ya-Fei Wang et al. · The Lancet Haematology · 0 citations

Sep 2026

Si-Si-Gu-Ben granules alleviate diarrhea-predominant irritable bowel syndrome by modulating gut microbiota and suppressing the TLR4/NF-κB pathway: A combined clinical and animal study.

ETHNOPHARMACOLOGICAL RELEVANCE Si-Si-Gu-Ben (SSGB), a traditional Chinese medicinal formula derived from the theory of "warming the spleen and kidney to arrest diarrhea," is frequently prescribed for diarrhea-predominant irritable bowel syndrome (IBS-D) in clinical practice, yet its pharmacological mechanisms remain in...

Yun-Jiao Xu, Wen-Di Wu, Zhi-Bi Zhang et al. · Journal of Ethnopharmacology · 0 citations